Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis-Reference-Cited by-同舟云学术

Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis

Published:2022-03-02 Issue:11 Volume:18 Page:2327-2340
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Lecca Daniela¹,Jung Yoo Jin¹²,Scerba Michael T.¹,Hwang Inho³,Kim Yu Kyung³,Kim Sun³,Modrow Sydney⁴,Tweedie David¹,Hsueh Shih‐Chang¹,Liu Dong¹,Luo Weiming¹,Glotfelty Elliot¹⁵,Li Yazhou¹,Wang Jia‐Yi⁶⁷⁸,Luo Yu⁹,Hoffer Barry J.¹⁰,Kim Dong Seok³¹¹,McDevitt Ross A.⁴,Greig Nigel H.¹

Affiliation:

1. Drug Design & Development Section Translational Gerontology Branch Intramural Research Program National Institute on Aging NIH Baltimore Maryland USA

2. Stanford Neurosciences Interdepartmental Program Stanford University School of Medicine Stanford California USA

3. Aevis Bio, Inc. Daejeon Republic of Korea

4. Comparative Medicine Section National Institute on Aging Baltimore Maryland USA

5. Department of Neuroscience Karolinska Institutet Stockholm Sweden

6. Graduate Institute of Medical Sciences Taipei Medical University Taipei Taiwan

7. Department of Neurosurgery Taipei Medical University Hospital Taipei Medical University Taipei Taiwan

8. Neuroscience Research Center Taipei Medical University Taipei Taiwan

9. Department of Molecular Genetics and Biochemistry College of Medicine University of Cincinnati Cincinnati Ohio USA

10. Department of Neurological Surgery Case Western Reserve University Hospital Cleveland Ohio USA

11. AevisBio, Inc. Gaithersburg Maryland USA

Funder

Ministry of Science and Technology, Taiwan

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12610

Reference68 articles.

1. Alzheimer’s drugs: Does reducing amyloid work?

2. Treatments for Alzheimer's disease emerge

3. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD36-mediated ROS/PI3K/AKT signaling pathway exacerbates cognitive impairment in APP/PS1 mice after noise exposure;Science of The Total Environment;2024-11

2. The role of TrkB signaling-mediated synaptic plasticity in the antidepressant properties of catalpol, the main active compound of Rehmannia glutinosa Libosch.;Journal of Ethnopharmacology;2024-10

3. “Let's talk about sex, inflammaging, and cognition, baby”: A meta-analysis and meta-regression of 106 case-control studies on mild cognitive impairment and Alzheimer's disease;Brain, Behavior, & Immunity - Health;2024-10

4. KIT-13, a novel plasmalogen derivative, attenuates neuroinflammation and amplifies cognition;Frontiers in Cell and Developmental Biology;2024-09-02

5. 2-(Piperidin-3-yl)phthalimides reduce classical markers of cellular inflammation in LPS-challenged RAW 264.7 cells and also demonstrate potentially relevant sigma and serotonin receptor affinity in membrane preparations;Bioorganic & Medicinal Chemistry Letters;2024-09